A new paraneoplastic biomarker
Dr. Anastasia Zekeridou discusses the main takeaways from her paper on a new paraneoplastic biomarker.
20 Aug 20191min
"Evergreen" Drug Prices
Prof. Robin Feldman discusses "evergreen" drug pricing, from her paper in the Journal of Law and the Biosciences, which you can read here: https://academic.oup.com/jlb/article/5/3/590/5232981.
19 Aug 20191min
Sex in Parkinson disease
Dr. Jill Farmer offers tips to give patients related to sex in Parkinson disease.
14 Aug 20191min
Impulse control and RBD in PD
Dr. Michele Hu and discuss the take-home message from her and Dr. David Okai's paper on a longitudinal study of the severity of impulse control disorders in Parkinson disease and RBD.
13 Aug 20191min
CRISPR babies
Dr. Heidi Ledford, senior science reporter for Nature, discusses the next steps in gene editing technology.
12 Aug 20191min
Non-motor symptoms of Parkinson disease
Dr. Jill Farmer discusses recognition and treatment of non-motor symptoms of Parkinson disease.
9 Aug 20191min
Galcanezumab in cluster headache
Dr. Teshamae Monteith discusses the use of galcanezumab in the treatment of cluster headache.
8 Aug 20192min
Managing Parkinson disease and "on and off" phenomena
Dr. Jill Farmer discusses "on" and "off" phenomena of Parkinson management.
7 Aug 20192min
